These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11729033)

  • 1. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.
    Rabiner EA; Bhagwagar Z; Gunn RN; Sargent PA; Bench CJ; Cowen PJ; Grasby PM
    Am J Psychiatry; 2001 Dec; 158(12):2080-2. PubMed ID: 11729033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans.
    Martinez D; Hwang D; Mawlawi O; Slifstein M; Kent J; Simpson N; Parsey RV; Hashimoto T; Huang Y; Shinn A; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
    Neuropsychopharmacology; 2001 Mar; 24(3):209-29. PubMed ID: 11166513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
    Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: preliminary analyses.
    Martinez D; Mawlawi O; Hwang DR; Kent J; Simpson N; Parsey RV; Hashimoto T; Slifstein M; Huang Y; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
    Nucl Med Biol; 2000 Jul; 27(5):523-7. PubMed ID: 10962261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
    J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies.
    Martinez D; Broft A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(8):844-53. PubMed ID: 11063979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy.
    Rabiner EA; Gunn RN; Castro ME; Sargent PA; Cowen PJ; Koepp MJ; Meyer JH; Bench CJ; Harrison PJ; Pazos A; Sharp T; Grasby PM
    Neuropsychopharmacology; 2000 Sep; 23(3):285-93. PubMed ID: 10942852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression.
    Segrave R; Nathan PJ
    Hum Psychopharmacol; 2005 Apr; 20(3):163-74. PubMed ID: 15648095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ; de Diego-Adeliño J; Ballesteros J; Puigdemont D; Oller S; Santos B; Álvarez E; Artigas F; Pérez V
    J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
    Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L
    Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography.
    Andrée B; Thorberg SO; Halldin C; Farde L
    Psychopharmacology (Berl); 1999 Jun; 144(3):303-5. PubMed ID: 10435400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635.
    Hirani E; Opacka-Juffry J; Gunn R; Khan I; Sharp T; Hume S
    Synapse; 2000 Jun; 36(4):330-41. PubMed ID: 10819911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
    Räsänen P; Hakko H; Tiihonen J
    J Clin Psychopharmacol; 1999 Aug; 19(4):297-302. PubMed ID: 10440455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
    Liu Y; Zhou X; Zhu D; Chen J; Qin B; Zhang Y; Wang X; Yang D; Meng H; Luo Q; Xie P
    Hum Psychopharmacol; 2015 May; 30(3):132-42. PubMed ID: 25689398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?
    Rabiner EA; Bhagwagar Z; Gunn RN; Cowen PJ; Grasby PM
    Neuropsychopharmacology; 2004 Sep; 29(9):1688-98. PubMed ID: 15127080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of (+/-)-pindolol over increased extracellular 5-HT level induced by fluvoxamine: regional difference in effect among the raphe, dorsal hippocampus and prefrontal cortex as measured by in vivo microdialysis technique].
    Nakada S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):51-60. PubMed ID: 11062862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.